BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tedder RS, Rodger AJ, Fries L, Ijaz S, Thursz M, Rosenberg W, Naoumov N, Banatvala J, Williams R, Dusheiko G. The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call. Clin Infect Dis. 2013;56:951-960. [PMID: 23223601 DOI: 10.1093/cid/cis1013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Owiti JA, Greenhalgh T, Sweeney L, Foster GR, Bhui KS. Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review. BMC Public Health 2015;15:151. [PMID: 25886390 DOI: 10.1186/s12889-015-1476-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
2 Kennedy PTF, Litwin S, Dolman GE, Bertoletti A, Mason WS. Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks. Viruses 2017;9:E96. [PMID: 28468285 DOI: 10.3390/v9050096] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
3 May S, Mandal S, Keel P, Haywood B, Ngui SL, Ramsay M, Tedder RS, Ijaz S. Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales. J Infect Dis 2018;218:726-33. [PMID: 29688415 DOI: 10.1093/infdis/jiy209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Clark-Wright J, Hudson P, McCloskey C, Carroll S. Burden of selected infectious diseases covered by UK childhood vaccinations: systematic literature review. Future Microbiol 2020;15:1679-88. [PMID: 33207948 DOI: 10.2217/fmb-2020-0170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liou IW, Nguyen MH. The Cascade of Care in Chronic Hepatitis B. Curr Hepatology Rep 2016;15:209-19. [DOI: 10.1007/s11901-016-0316-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
6 Niederau C. Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit. World J Gastroenterol 2014; 20(33): 11595-11617 [PMID: 25206267 DOI: 10.3748/wjg.v20.i33.11595] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
7 Sewell J, Capocci S, Johnson J, Solamalai A, Hopkins S, Cropley I, Webster DP, Lipman M. Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis. J Infect 2015;70:317-23. [PMID: 25452045 DOI: 10.1016/j.jinf.2014.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Hill A, Gotham D, Cooke G, Bhagani S, Andrieux-meyer I, Cohn J, Fortunak J. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries. Journal of Virus Eradication 2015;1:103-10. [DOI: 10.1016/s2055-6640(20)30484-2] [Cited by in Crossref: 21] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ijaz S, Derrick J, Shute J, Ireland G, Hayden I, Ngui SL, Mandal S, Tedder RS. Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure. Clin Infect Dis 2021:ciab622. [PMID: 34251456 DOI: 10.1093/cid/ciab622] [Reference Citation Analysis]
10 Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76-S86. [PMID: 25920093 DOI: 10.1016/j.jhep.2015.01.018] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 20.0] [Reference Citation Analysis]
11 Sagnelli C, Ciccozzi M, Coppola N, Minichini C, Lo Presti A, Starace M, Alessio L, Macera M, Cella E, Gualdieri L, Caprio N, Pasquale G, Sagnelli E. Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples. J Med Virol. 2017;89:1015-1024. [PMID: 27805272 DOI: 10.1002/jmv.24724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
12 Rosenberg GK, Lattimore S, Brailsford SR, Hewitt PE, Tettmar KI, Kitchen AD, Ijaz S, Tedder RS. Acute hepatitis B in blood donors over a 5-year period in England and North Wales: who is getting infected?: Phylogeny of Acute Hepatitis B in UK Donors. Transfusion 2014;54:1660-5. [DOI: 10.1111/trf.12497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Koukoulioti E, Brodzinski A, Mihm U, Sarrazin C, Jung M, Schott E, Fülöp B, Schlosser B, Berg T, van Bömmel F. Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections. European Journal of Gastroenterology & Hepatology 2019;31:845-52. [DOI: 10.1097/meg.0000000000001351] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Godbole G, Irish D, Basarab M, Mahungu T, Fox-Lewis A, Thorne C, Jacobs M, Dusheiko G, Rosenberg WM, Suri D, Millar AD, Nastouli E. Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals. BMC Pregnancy Childbirth 2013;13:222. [PMID: 24289183 DOI: 10.1186/1471-2393-13-222] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Jeffery-Smith A, Hubb J, Oliver A, Tong CY. An apparent low level of hepatitis B surface antigen (HBsAg) in the presence of significant viral replication. J Clin Virol 2016;77:111-4. [PMID: 26705961 DOI: 10.1016/j.jcv.2015.11.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
16 Davison S. Management of chronic hepatitis B infection. Arch Dis Child. 2014;99:1037-1042. [PMID: 24812303 DOI: 10.1136/archdischild-2013-304925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Nguyen VH, Le AK, Trinh HN, Chung M, Johnson T, Wong C, Wong C, Zhang J, Li J, Levitt BS, Nguyen HA, Nguyen KK, Henry L, Cheung R, Nguyen MH. Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices. Clinical Gastroenterology and Hepatology 2019;17:957-967.e7. [DOI: 10.1016/j.cgh.2018.10.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
18 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Papastergiou V, Thalassinos E, Mantzoukis K, Rodriguez-Peralvarez M, O'Brien J, Noel-Storr A, Papatheodoridis GV, Davidson B, Burroughs AK. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation. J Viral Hepat 2016;23:139-49. [PMID: 26444996 DOI: 10.1111/jvh.12469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Andersson MI, Maponga TG, Ijaz S, Barnes J, Theron GB, Meredith SA, Preiser W, Tedder RS. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine 2013;31:5579-84. [PMID: 23973500 DOI: 10.1016/j.vaccine.2013.08.028] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
20 Evlampidou I, Hickman M, Irish C, Young N, Oliver I, Gillett S, Cochrane A. Low hepatitis B testing among migrants: a cross-sectional study in a UK city. Br J Gen Pract 2016;66:e382-91. [PMID: 27025556 DOI: 10.3399/bjgp16X684817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Papatheodoridis GV, Tsochatzis E, Hardtke S, Wedemeyer H. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review. Liver Int 2014;34:1452-63. [PMID: 24750532 DOI: 10.1111/liv.12565] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
22 Williams R, Holt AP. Screening immigrants for tuberculosis--why not for HBV infection? Lancet. 2013;381:2164-2165. [PMID: 23791343 DOI: 10.1016/s0140-6736(13)61438-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
23 Harvala H, Reynolds C, Gibney Z, Derrick J, Ijaz S, Davison KL, Brailsford S. Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety? Transfusion 2021;61:2402-13. [PMID: 34114670 DOI: 10.1111/trf.16543] [Reference Citation Analysis]
24 Keel P, Edwards G, Flood J, Nixon G, Beebeejaun K, Shute J, Poh J, Millar A, Ijaz S, Parry J, Mandal S, Ramsay M, Amirthalingam G. Assessing the impact of a nurse-delivered home dried blood spot service on uptake of testing for household contacts of hepatitis B-infected pregnant women across two London trusts. Epidemiol Infect 2016;144:2087-97. [PMID: 26833270 DOI: 10.1017/S0950268815003325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tan M, Bhadoria AS, Cui F, Tan A, Van Holten J, Easterbrook P, Ford N, Han Q, Lu Y, Bulterys M, Hutin Y. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:106-19. [PMID: 33197397 DOI: 10.1016/S2468-1253(20)30307-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
26 Talwalkar JA. Health services and policy research in hepatology. Curr Opin Gastroenterol 2014;30:272-8. [PMID: 24662844 DOI: 10.1097/MOG.0000000000000064] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Yuen MF, Ahn SH, Chen DS, Chen PJ, Dusheiko GM, Hou JL, Maddrey WC, Mizokami M, Seto WK, Zoulim F, Lai CL. Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations. J Clin Gastroenterol 2016;50:286-94. [PMID: 26840752 DOI: 10.1097/MCG.0000000000000478] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
28 Roche R, Simmons R, Crawshaw AF, Fisher P, Pareek M, Morton W, Shryane T, Poole K, Verma A, Campos-Matos I, Mandal S. What do primary care staff know and do about blood borne virus testing and care for migrant patients? A national survey. BMC Public Health 2021;21:336. [PMID: 33573638 DOI: 10.1186/s12889-020-10068-x] [Reference Citation Analysis]
29 Boyd A, Gozlan J, Carrat F, Rougier H, Girard PM, Lacombe K, Bottero J. Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign. Epidemiol Infect 2018;147:e16. [PMID: 30264683 DOI: 10.1017/S0950268818002650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]